United Therapeutics Corp (UTHR) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "UTHR"
      ],
      "issuer_cik": "0001082554",
      "owner_cik": "0001106578",
      "accession_number": "0001106578-26-000170",
      "form_type": "4",
      "filing_date": "2026-10-23",
      "period_of_report": "2026-10-22",
      "issuer_name": "UNITED THERAPEUTICS Corp",
      "issuer_trading_symbol": "UTHR",
      "owner_name": "ROTHBLATT MARTINE A",
      "is_director": true,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "Chairperson & CEO",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-22",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 400,
      "transaction_price_per_share": 581.832,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 331559,
      "transaction_value": 232732.8,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "I",
      "nature_of_ownership": "by Trust",
      "footnotes": [
        {
          "id": "F1",
          "description": "This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."
        },
        {
          "id": "F14",
          "description": "This transaction was executed in multiple trades at prices ranging from $581.52 to $582.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."
        },
        {
          "id": "F2",
          "description": "Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."
        }
      ]
    },
    {
      "tickers": [
        "UTHR"
      ],
      "issuer_cik": "0001082554",
      "owner_cik": "0001106578",
      "accession_number": "0001106578-26-000170",
      "form_type": "4",
      "filing_date": "2026-10-23",
      "period_of_report": "2026-10-22",
      "issuer_name": "UNITED THERAPEUTICS Corp",
      "issuer_trading_symbol": "UTHR",
      "owner_name": "ROTHBLATT MARTINE A",
      "is_director": true,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "Chairperson & CEO",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-22",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 74,
      "transaction_price_per_share": 562.97,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 333869,
      "transaction_value": 41659.78,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "I",
      "nature_of_ownership": "by Trust",
      "footnotes": [
        {
          "id": "F1",
          "description": "This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."
        },
        {
          "id": "F3",
          "description": "This transaction was executed in multiple trades at prices ranging from $562.36 to $563.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."
        },
        {
          "id": "F2",
          "description": "Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.